Margriet Oosterveld

6PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyEpidemiological modellingEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 12, 2025
Prospective Validation of Circulating Tumor DNA Measurable Residual Disease After First-Line Therapy in Large B-Cell Lymphoma.

Steven Wang, Marcel Nijland, Leonie Strobbe

|Jan 08, 2024
Distinct peripheral T-cell and NK-cell profiles in HGBL-MYC/BCL2 vs patients with DLBCL NOS.

A Vera de Jonge, Carolien Duetz, Wassilis S C Bruins

|Dec 14, 2021
Web-Based Return of Individual Patient-Reported Outcome Results Among Patients With Lymphoma: Randomized Controlled Trial.

Simone Oerlemans, Lindy Paulina Johanna Arts, Jacobien M Kieffer

|May 04, 2021
Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study.

Claudia A M Stege, Kazem Nasserinejad, Ellen van der Spek

|May 15, 2020
Web-Based Self-Management for Patients With Lymphoma: Assessment of the Reach of Intervention of a Randomized Controlled Trial.

Lindy P J Arts, Simone Oerlemans, Eduardus F M Posthuma

Pageof 1